RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., the leader in metabolomics, biomarker discovery and biochemical analysis, announced today that they will give three presentations representing the company’s research into biomarkers at the European Association for the Study of Diabetes (EASD) Meeting in Lisbon, Portugal, September 12-18. Also presenting the EASD’s 43rd Claude Bernard keynote lecture is Metabolon collaborator, Ele Ferrannini, M.D., Professor of Medicine, University of Pisa, Italy, on Friday, September 16th. The lecture is from 1:00 p.m.-2:00 p.m. and is entitled “Diabetes: Brief History of a Conspiracy.” Please Note: UNDER EMBARGO until 1:01 p.m. on 9/16,
